BRIEF published on 08/08/2024 at 20:05, 2 years 1 month ago PolyPeptide appoints Chief Commercial Officer Chief Commercial Officer PolyPeptide Stéphane Varray Pharmaceutical Ingredients GLP-1 Therapies
BRIEF published on 08/08/2024 at 20:05, 2 years 1 month ago PolyPeptide nomme un directeur commercial PolyPeptide Directeur Commercial Stéphane Varray Ingrédients Pharmaceutiques Thérapies GLP-1
PRESS RELEASE published on 08/08/2024 at 20:00, 2 years 1 month ago PolyPeptide appoints Chief Commercial Officer PolyPeptide Group AG announces the appointment of Stéphane Varray as Chief Commercial Officer and member of the Management Committee, effective January 2025 Growth Strategy Pharmaceuticals Chief Commercial Officer PolyPeptide Stéphane Varray
BRIEF published on 04/10/2024 at 19:28, 2 years 5 months ago PolyPeptide annonce des résultats positifs lors de l'assemblée générale annuelle 2024 Gouvernance D'Entreprise Approbation Des Actionnaires Assemblée Générale Annuelle 2024 Groupe Polypeptide États Financiers 2023
BRIEF published on 04/10/2024 at 19:28, 2 years 5 months ago PolyPeptide Announces Positive Outcomes at 2024 Annual General Meeting Shareholder Approval Corporate Governance Annual General Meeting 2024 PolyPeptide Group Financial Statements 2023
PRESS RELEASE published on 04/10/2024 at 19:23, 2 years 5 months ago PolyPeptide announces results of the annual General Meeting 2024 PolyPeptide Group AG announces successful approval of all proposals at annual General Meeting 2024. Details include re-election of Board members and approval of key financial matters Board Of Directors Annual General Meeting Shareholders PolyPeptide Group AG Financial Approvals
BRIEF published on 03/19/2024 at 07:05, 2 years 6 months ago PolyPeptide Group annonce son assemblée générale annuelle 2024 Conseil D'administration Gouvernance D'Entreprise Assemblée Générale Annuelle Groupe Polypeptide Industrie Pharmaceutique
BRIEF published on 03/19/2024 at 07:05, 2 years 6 months ago PolyPeptide Group Announces Annual General Meeting 2024 Board Of Directors Annual General Meeting Pharmaceutical Industry Corporate Governance PolyPeptide Group
PRESS RELEASE published on 03/19/2024 at 07:00, 2 years 6 months ago PolyPeptide publishes invitation to the annual General Meeting 2024 PolyPeptide Group AG publishes invitation to the annual General Meeting 2024 with details of proposed agenda items and changes to the Board of Directors Board Of Directors Annual General Meeting 2024 AGM 2024 PolyPeptide Group AG Remuneration Committee
BRIEF published on 03/12/2024 at 06:50, 2 years 6 months ago PolyPeptide annonce une croissance record de ses revenus au second semestre 2023 Performance Financière Hausse Des Revenus Médicaments Groupe Polypeptide Améliorations Opérationnelles
Published on 10/02/2026 at 00:30, 3 hours 51 minutes ago Immutable Holdings Provides Corporate Update
Published on 10/01/2026 at 23:05, 5 hours 16 minutes ago Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 6 hours 21 minutes ago Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/02/2026 at 04:05, 16 minutes ago Angel Aligner Upgrades Torque Ridges to "Pressure Points" in Europe
Published on 10/02/2026 at 00:01, 4 hours 20 minutes ago PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Published on 10/01/2026 at 23:15, 5 hours 6 minutes ago CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 7 hours 36 minutes ago Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 7 hours 51 minutes ago Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 19:00, 9 hours 21 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 19:00, 9 hours 21 minutes ago AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye
Published on 10/01/2026 at 18:40, 9 hours 40 minutes ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:40, 9 hours 40 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026
Published on 10/01/2026 at 18:07, 10 hours 14 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
